Cancer Diagnostics & Biomarkers
Part of Healthcare - Oncology
 NTRA | Natera, Inc. Common Stock | $38.7b | $308.10 | -3.4% | 1.3M |
 GH | Guardant Health, Inc. Common Stock | $21.7b | $157.38 | -3.5% | 1.4M |
 BLLN | BillionToOne, Inc. Class A Common Stock | $6.4b | $92.15 | -38.9% | 3.7M |
 CAI | Caris Life Sciences, Inc. Common Stock | $4.4b | $20.10 | +21.5% | 10.5M |
 VCYT | Veracyte, Inc. | $3.6b | $46.55 | -0.0% | 715.6K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $3.6b | $23.55 | -4.1% | 1.9M |
 GRAL | GRAIL, Inc. Common Stock | $2.9b | $63.45 | -14.5% | 1.8M |
 NEO | NeoGenomics, Inc. | $2.0b | $15.78 | -1.1% | 1.6M |
 PSNL | Personalis, Inc. Common Stock | $1.4b | $13.00 | -3.7% | 1.6M |
 CSTL | Castle Biosciences, Inc. Common Stock | $0.9b | $30.43 | +0.1% | 718.5K |
 ANGO | AngioDynamics, Inc. | $0.6b | $15.05 | +0.5% | 271.9K |
 TOI | The Oncology Institute, Inc. Common Stock | $0.5b | $5.19 | 0.0% | N/A |
 FLGT | Fulgent Genetics, Inc. Common Stock | $470.0m | $18.56 | +0.2% | 208.5K |
 MYGN | Myriad Genetics Inc | $288.9m | $3.21 | +1.0% | 2.1M |
 BDSX | Biodesix, Inc. Common Stock | $219.5m | $22.23 | -2.4% | 196.9K |
 LUCD | Lucid Diagnostics Inc. Common Stock | $166.3m | $0.97 | -4.5% | 809.9K |
 SRTS | Sensus Healthcare, Inc | $48.1m | $2.98 | -0.7% | 10.6K |
 PRPO | Precipio, Inc. Common Stock | $39.6m | $23.43 | -0.2% | 38.3K |
 PAVM | PAVmed Inc. Common Stock | $39.4m | $4.84 | 0.0% | 3.2K |
 QUCY | Quantum Cyber N.V. Ordinary Shares | $28.7m | $1.40 | -4.1% | 500.2K |
 MDXH | MDxHealth SA Ordinary Shares | $23.4m | $0.46 | -0.0% | 100.6K |
 ADVB | Advanced Biomed Inc. Common Stock | $13.2m | $7.25 | -5.0% | 52.0K |
 VNRX | VolitionRx Limited | $9.6m | $0.76 | -5.7% | 542.8K |
 ZCMD | Zhongchao Inc. Class A Ordinary Shares | $7.0m | $1.06 | -6.8% | 2.2M |
 AIDX | 20/20 Biolabs, Inc. Common Stock | $5.2m | $0.44 | 0.0% | 42.9K |
 BIAF | bioAffinity Technologies, Inc. Common Stock | $3.9m | $0.53 | 0.0% | 203.5K |
 ALBT | Avalon GloboCare Corp. Common Stock | $3.5m | $0.28 | 0.0% | N/A |
 ONCO | Onconetix, Inc. Common Stock | $3.0m | $0.90 | -8.6% | 387.8K |